Literature DB >> 25666468

Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.

Mark A Espeland1, Jeffery Probstfield2, Donald Hire3, J Bruce Redmon4, Gregory W Evans3, Mace Coday5, Cora E Lewis6, Karen C Johnson5, Sharon Wilmoth3, Judy Bahnson3, Michael F Dulin7, Jennifer B Green8, William C Knowler9, Abbas Kitabchi5, Anne L Murillo2, Kwame Osei10, Shakaib U Rehman11, William C Cushman12.   

Abstract

BACKGROUND: The relative effectiveness of 3 approaches to blood pressure control-(i) an intensive lifestyle intervention (ILI) focused on weight loss, (ii) frequent goal-based monitoring of blood pressure with pharmacological management, and (iii) education and support-has not been established among overweight and obese adults with type 2 diabetes who are appropriate for each intervention.
METHODS: Participants from the Action for Health in Diabetes (Look AHEAD) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) cohorts who met criteria for both clinical trials were identified. The proportions of these individuals with systolic blood pressure (SBP) <140 mm Hg from annual standardized assessments over time were compared with generalized estimating equations.
RESULTS: Across 4 years among 480 Look AHEAD and 1,129 ACCORD participants with baseline SBPs between 130 and 159 mm Hg, ILI (OR = 1.46; 95% CI = [1.18-1.81]) and frequent goal-based monitoring with pharmacotherapy (OR = 1.51; 95% CI = [1.16-1.97]) yielded higher rates of blood pressure control compared to education and support. The intensive behavioral-based intervention may have been more effective among individuals with body mass index >30 kg/m2, while frequent goal-based monitoring with medication management may be more effective among individuals with lower body mass index (interaction P = 0.047).
CONCLUSIONS: Among overweight and obese adults with type 2 diabetes, both ILI and frequent goal-based monitoring with pharmacological management can be successful strategies for blood pressure control. CLINICAL TRIALS REGISTRY: clinicaltrials.gov identifiers NCT00017953 (Look AHEAD) and NCT00000620 (ACCORD). © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; blood pressure control; blood pressure monitoring; comparative effectiveness; diabetes; hypertension; lifestyle intervention; obesity.

Mesh:

Substances:

Year:  2015        PMID: 25666468      PMCID: PMC4506323          DOI: 10.1093/ajh/hpu292

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  21 in total

1.  The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus.

Authors:  Paul J Godley; Susan K Maue; Eileen W Farrelly; Feride Frech
Journal:  Am J Manag Care       Date:  2005-04       Impact factor: 2.229

Review 2.  The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it.

Authors:  Thomas A Wadden; Delia Smith West; Linda Delahanty; John Jakicic; Jack Rejeski; Don Williamson; Robert I Berkowitz; David E Kelley; Christine Tomchee; James O Hill; Shiriki Kumanyika
Journal:  Obesity (Silver Spring)       Date:  2006-05       Impact factor: 5.002

3.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

5.  Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study.

Authors:  George Bray; Edward Gregg; Steven Haffner; Xavier F Pi-Sunyer; Lynne E WagenKnecht; Michael Walkup; Rena Wing
Journal:  Diab Vasc Dis Res       Date:  2006-12       Impact factor: 3.291

Review 6.  Long-term weight loss from lifestyle intervention benefits blood pressure?: a systematic review.

Authors:  Lorna Aucott; Helen Rothnie; Linda McIntyre; Mohan Thapa; Charles Waweru; Denise Gray
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

Review 7.  Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  David C Goff; Hertzel C Gerstein; Henry N Ginsberg; William C Cushman; Karen L Margolis; Robert P Byington; John B Buse; Saul Genuth; Jeffrey L Probstfield; Denise G Simons-Morton
Journal:  Am J Cardiol       Date:  2007-04-12       Impact factor: 2.778

8.  Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

Authors:  John B Buse; J Thomas Bigger; Robert P Byington; Lawton S Cooper; William C Cushman; William T Friedewald; Saul Genuth; Hertzel C Gerstein; Henry N Ginsberg; David C Goff; Richard H Grimm; Karen L Margolis; Jeffrey L Probstfield; Denise G Simons-Morton; Mark D Sullivan
Journal:  Am J Cardiol       Date:  2007-04-16       Impact factor: 2.778

9.  Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  William C Cushman; Richard H Grimm; Jeffrey A Cutler; Gregory W Evans; Sarah Capes; Marshall A Corson; Laurie S Sadler; Michael H Alderman; Kevin Peterson; Alain Bertoni; Jan N Basile
Journal:  Am J Cardiol       Date:  2007-04-16       Impact factor: 2.778

10.  Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.

Authors:  Mark A Espeland; Henry A Glick; Alain Bertoni; Frederick L Brancati; George A Bray; Jeanne M Clark; Jeffrey M Curtis; Caitlin Egan; Mary Evans; John P Foreyt; Siran Ghazarian; Edward W Gregg; Helen P Hazuda; James O Hill; Don Hire; Edward S Horton; Van S Hubbard; John M Jakicic; Robert W Jeffery; Karen C Johnson; Steven E Kahn; Tina Killean; Abbas E Kitabchi; William C Knowler; Andrea Kriska; Cora E Lewis; Marsha Miller; Maria G Montez; Anne Murillo; David M Nathan; Ebenezer Nyenwe; Jennifer Patricio; Anne L Peters; Xavier Pi-Sunyer; Henry Pownall; J Bruce Redmon; Julia Rushing; Donna H Ryan; Monika Safford; Adam G Tsai; Thomas A Wadden; Rena R Wing; Susan Z Yanovski; Ping Zhang
Journal:  Diabetes Care       Date:  2014-09       Impact factor: 19.112

View more
  10 in total

1.  Efficient Transduction of Human and Rhesus Macaque Primary T Cells by a Modified Human Immunodeficiency Virus Type 1-Based Lentiviral Vector.

Authors:  Huan He; Jing Xue; Weiming Wang; Lihong Liu; Chaobaihui Ye; Zhe Cong; Jason T Kimata; Chuan Qin; Paul Zhou
Journal:  Hum Gene Ther       Date:  2016-12-29       Impact factor: 5.695

2.  Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial.

Authors:  Mark A Espeland; Owen Carmichael; Kathleen Hayden; Rebecca H Neiberg; Anne B Newman; Jeffery N Keller; Thomas A Wadden; Stephen R Rapp; James O Hill; Edward S Horton; Karen C Johnson; Lynne Wagenknecht; Rena R Wing
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-03-14       Impact factor: 6.053

3.  Setting and Method of Measurement Affect Blood Pressure Readings in Older Veterans.

Authors:  Justin J Cheng; Steven C Castle; Erin H Blanchard; David Segovia; Cathy C Lee
Journal:  Fed Pract       Date:  2018-06

4.  Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes.

Authors:  Om P Ganda; Joanna Mitri
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

Review 5.  Blood Pressure Control and Protection of the Aging Brain.

Authors:  Nasratullah Wahidi; Alan J Lerner
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 6.  Effects of Hypertension on Alzheimer's Disease and Related Disorders.

Authors:  Joseph E Malone; Mohamed I Elkasaby; Alan J Lerner
Journal:  Curr Hypertens Rep       Date:  2022-09-20       Impact factor: 4.592

7.  Relative differences in resting-state brain connectivity associated with long term intensive lifestyle intervention.

Authors:  Ramon Casanova; Satoru Hayasaka; Santiago Saldana; Nick R Bryan; Kathryn E Demos; Lisa Desiderio; Kirk I Erickson; Mark A Espeland; Ilya M Nasrallah; Thomas Wadden; Paul J Laurienti
Journal:  Psychoneuroendocrinology       Date:  2016-09-23       Impact factor: 4.905

8.  Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment.

Authors:  Mark A Espeland; José A Luchsinger; Laura D Baker; Rebecca Neiberg; Steven E Kahn; Steven E Arnold; Rena R Wing; George L Blackburn; George Bray; Mary Evans; Helen P Hazuda; Robert W Jeffery; Valerie M Wilson; Jeanne M Clark; Mace Coday; Kathryn Demos-McDermott; John P Foreyt; Frank Greenway; James O Hill; Edward S Horton; John M Jakicic; Karen C Johnson; William C Knowler; Cora E Lewis; David M Nathan; Anne Peters; Xavier Pi-Sunyer; Henry Pownall; Thomas A Wadden; Stephen R Rapp
Journal:  Neurology       Date:  2017-04-26       Impact factor: 9.910

9.  Refining determinants of associations of visit-to-visit blood pressure variability with cardiovascular risk: results from the Action to Control Cardiovascular Risk in Diabetes Trial.

Authors:  Daniel S Nuyujukian; Jin J Zhou; Juraj Koska; Peter D Reaven
Journal:  J Hypertens       Date:  2021-11-01       Impact factor: 4.844

10.  Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention.

Authors:  Mark A Espeland; Kirk Erickson; Rebecca H Neiberg; John M Jakicic; Thomas A Wadden; Rena R Wing; Lisa Desiderio; Guray Erus; Meng-Kang Hsieh; Christos Davatzikos; Barbara J Maschak-Carey; Paul J Laurienti; Kathryn Demos-McDermott; R Nick Bryan
Journal:  Diabetes Care       Date:  2016-03-29       Impact factor: 19.112

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.